Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer

AIMS: Small cell lung cancer (SCLC) carries a poor prognosis, and the systemic therapies currently used as treatments are only modestly effective, as demonstrated by a low 5-year survival at only ∼5%. In this retrospective collected from March 2013 to study, we performed comprehensive genomic profil...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, J S, Wang, K, Elkadi, O R, Tarasen, A, Foulke, L, Sheehan, C E, Otto, G A, Palmer, G, Yelensky, R, Lipson, D, Chmielecki, J, Ali, S M, Elvin, J, Morosini, D, Miller, V A, Stephens, P J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145440/
https://www.ncbi.nlm.nih.gov/pubmed/24978188
http://dx.doi.org/10.1136/jclinpath-2014-202447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145440/
https://www.ncbi.nlm.nih.gov/pubmed/24978188
http://dx.doi.org/10.1136/jclinpath-2014-202447

Ejemplares similares